[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,109,436
  • Shares Outstanding, K 28,560
  • Annual Sales, $ 2,530 M
  • Annual Income, $ 451,120 K
  • EBIT $ 591 M
  • EBITDA $ 619 M
  • 60-Month Beta 1.19
  • Price/Sales 4.84
  • Price/Cash Flow 25.20
  • Price/Book 20.46

Options Overview Details

View History
  • Implied Volatility 35.69% (+1.92%)
  • Historical Volatility 81.90%
  • IV Percentile 29%
  • IV Rank 22.01%
  • IV High 67.09% on 04/22/26
  • IV Low 26.83% on 08/15/25
  • Expected Move (DTE 5) 12.75 (3.01%)
  • Put/Call Vol Ratio 2.78
  • Today's Volume 68
  • Volume Avg (30-Day) 241
  • Put/Call OI Ratio 2.67
  • Today's Open Interest 4,014
  • Open Int (30-Day) 2,602
  • Expected Range 411.25 to 436.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $4.08
  • Number of Estimates 3
  • High Estimate $4.11
  • Low Estimate $4.03
  • Prior Year $3.10
  • Growth Rate Est. (year over year) +31.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
373.00 +13.67%
on 04/23/26
530.97 -20.15%
on 04/16/26
-96.65 (-18.56%)
since 04/08/26
3-Month
373.00 +13.67%
on 04/23/26
547.07 -22.50%
on 02/09/26
-118.04 (-21.78%)
since 02/06/26
52-Week
284.48 +49.04%
on 05/15/25
628.92 -32.58%
on 01/16/26
+123.19 (+40.95%)
since 05/08/25

Most Recent Stories

More News
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , May 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

MEDP : 424.00 (-1.10%)
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit

NEW YORK , May 7, 2026 /PRNewswire/ --

MEDP : 424.00 (-1.10%)
INVESTOR DEADLINE: Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO , May 7, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between...

MEDP : 424.00 (-1.10%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MEDP

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors...

MEDP : 424.00 (-1.10%)
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Backlog Deterioration: SueWallSt

Notice to Pension Funds, Asset Managers, and Fiduciaries

MEDP : 424.00 (-1.10%)
MEDP Fraud News: Medpace Sued for Securities Fraud Over Cancellation Rates and 16% Stock Drop – Contact BFA Law if You Lost Money

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to...

MEDP : 424.00 (-1.10%)
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , May 6, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

MEDP : 424.00 (-1.10%)
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After President Allegedly Oversaw Misleading Disclosures: Levi & Korsinsky

Executive Accountability: Jesse J. Geiger Named in Securities Action

MEDP : 424.00 (-1.10%)
MEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options

MEDP : 424.00 (-1.10%)
MEDP Shareholder Alert: Medpace Holdings, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm

NEW YORK , May 5, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP).

MEDP : 424.00 (-1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 442.80
2nd Resistance Point 436.65
1st Resistance Point 430.33
Last Price 424.00
1st Support Level 417.86
2nd Support Level 411.71
3rd Support Level 405.39

See More

52-Week High 628.92
Fibonacci 61.8% 497.34
Fibonacci 50% 456.70
Last Price 424.00
Fibonacci 38.2% 416.05
52-Week Low 284.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.